Efficacy and safety of weekly vitamin D3 in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial.
Luis Iván Lozano-PlataDavid Vega-MoralesJorge Antonio Esquivel-ValerioMario Alberto Garza-ElizondoDionicio Ángel Galarza-DelgadoKarina Silva-LunaGriselda Serna-PeñaJaneth Sifuentes-RamírezAlfredo de Jesús Garza-GuerraRaúl Díaz-Niño de RiveraPublished in: Clinical rheumatology (2021)
Clinical Trials.gov number: NCT03369379 Key Points • There are conflicting results in vitamin D to treat fibromyalgia. • In this double-blind, randomized controlled trial, we did not find a difference in the VAS nor FIQ with vitamin D supplementation. • The increase in vitamin D levels in the intervention group was corroborated.